Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...

As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of new vaccines, including an mRNA shot.

The current public-health risk is low, but the CDC is watching the situation carefully and working with states to monitor ...

HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Investing.com -- Moderna ...

Moderna Inc (MRNA) stock saw a decline, ending the day at $33.76 which represents a decrease of $-1.01 or -2.90% from the prior close of $34.77. The stock opened at $34.75 and touched a low of $33.34 ...

Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...

The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as ...